Your browser doesn't support javascript.
loading
Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced Staphylococcus aureus nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study.
Mangino, Julie E; Firstenberg, Michael S; Milewski, Rita K C; Rhys-Williams, William; Lees, James P; Dane, Aaron; Love, William G; Gonzalez Moreno, Jesus.
Afiliação
  • Mangino JE; Division of Infection Diseases, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States.
  • Firstenberg MS; William Novick Global Cardiac Alliance. Aurora, Colorado, United States.
  • Milewski RKC; Department of Surgery, Yale School of Medicine, New Haven, Connecticut, United States.
  • Rhys-Williams W; Destiny Pharma, Brighton, United Kingdom.
  • Lees JP; Destiny Pharma, Brighton, United Kingdom.
  • Dane A; Danestat Consulting Ltd, Macclesfield, United Kingdom.
  • Love WG; Destiny Pharma, Brighton, United Kingdom.
  • Gonzalez Moreno J; Destiny Pharma, Brighton, United Kingdom.
Infect Control Hosp Epidemiol ; 44(7): 1171-1173, 2023 Jul.
Article em En | MEDLINE | ID: mdl-36951472
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Procedimentos Cirúrgicos Cardíacos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Procedimentos Cirúrgicos Cardíacos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article